...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic–Mass Spectrometric Assay for Determination of Amphetamine and Methamphetamine Enantiomers and Its Application to Toxicology Cases
【24h】

Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic–Mass Spectrometric Assay for Determination of Amphetamine and Methamphetamine Enantiomers and Its Application to Toxicology Cases

机译:血液中的药物测试:验证型负离子化学电离气相色谱-质谱法测定苯丙胺和甲基苯丙胺对映异构体及其在毒理学案例中的应用

获取原文
           

摘要

Background: Enantioselective analysis of amphetamine (AM) or methamphetamine (MA) in urine is already a well-established tool for differentiation of illicit from therapeutic ingestion of AM or MA derivatives. However, because of the increasing importance of plasma or serum in analytical toxicology, a method for enantioselective analysis of AM and MA in these matrices is needed.Methods: AM and/or MA were extracted from 0.2 mL of blood plasma or serum by mixed-mode solid-phase extraction. After derivatization with S -(?)-heptafluorobutyrylprolyl chloride, the resulting diastereomers were separated by gas chromatography on a HP-5MS column during a 15-min program and detected by mass spectrometry in the negative-ion chemical ionization mode (NICI-GC-MS). The method was fully validated and applied to 50 samples from authentic toxicology cases.Results: The derivatized AM and MA enantiomers were well separated and sensitively detected. The method was linear from 5 to 250 μg/L per enantiomer with analytical recoveries, accuracy, and within- and between-run precision well within required limits. Extraction yields were 88.9–98.6%. Implications of concentrations and enantiomeric composition of AM and MA in the authentic samples were considered.Conclusions: This sensitive, reliable, rapid NICI-GC-MS assay is suitable for enantioselective determination of AM and MA in blood plasma or serum samples.
机译:背景:尿液中的苯丙胺(AM)或甲基苯丙胺(MA)的对映选择性分析已经是公认的从治疗性摄入AM或MA衍生物中区分非法药物的工具。但是,由于血浆或血清在分析毒理学中的重要性日益提高,因此需要一种对映体选择性分析这些基质中AM和MA的方法。方法:通过以下方法从0.2 mL血浆或血清中提取AM和/或MA:模式固相萃取。用S-(β)-七氟丁酰氯丙基衍生物衍生化后,在15分钟的程序中通过HP-5MS色谱柱的气相色谱分离所得非对映异构体,并通过质谱在负离子化学电离模式下进行检测(NICI-GC-多发性硬化症)。该方法已得到充分验证,可用于真实毒理学案例中的> 50个样品。结果:衍生化的AM和MA对映异构体可以很好地分离并灵敏地检测。该方法是线性的,对映体为5至250μg/ L,分析回收率,准确度以及运行内和运行间精密度均在要求的范围内。提取产率为88.9–98.6%。结论:该灵敏,可靠,快速的NICI-GC-MS测定方法适合对映测定血浆或血清样品中的AM和MA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号